Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s (Q36550842)
Jump to navigation
Jump to search
scientific article published on 5 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s |
scientific article published on 5 May 2012 |
Statements
1 reference
Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s (English)
1 reference
Josef S Smolen
1 reference
Arthur Kavanaugh
1 reference
Roy M Fleischmann
1 reference
Hartmut Kupper
1 reference
Laura Redden
1 reference
Benoit Guerette
1 reference
Sourav Santra
1 reference
5 May 2012
1 reference
1 reference
64-71
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference